140 results
Page 5 of 7
8-K
EX-5.1
jaagy6i3bynkvly6gd
7 Sep 18
Adaptimmune Therapeutics plc Announces Closing of Registered Direct Offering of American Depositary Shares
12:00am
8-K
EX-99.1
tw0vc7mq432
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
S-3ASR
0k6 n565uh1x
12 Jul 18
Automatic shelf registration
4:30pm
S-3ASR
EX-5.1
4sf7qnukm3adba s3z0t
12 Jul 18
Automatic shelf registration
4:30pm
8-K
EX-99.1
j5vyd4
6 Jul 18
Departure of Directors or Certain Officers
5:00pm
8-K
EX-14.1
avzaxwvo
24 Jul 17
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
8-K
EX-5.1
58wxdd01v3 1ks
10 Apr 17
Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering
12:00am
10-K
EX-10.19
skwfnlf4lc0jujyv
13 Mar 17
Annual report
12:00am
10-K
EX-10.16
szcuyi 1u2
13 Mar 17
Annual report
12:00am